Invention Grant
- Patent Title: Microbiome markers and therapies for autism spectrum disorders
-
Application No.: US16118061Application Date: 2018-08-30
-
Publication No.: US11542560B2Publication Date: 2023-01-03
- Inventor: Rosa Krajmalnik-Brown , Dae-Wook Kang , Jin Gyoon Park , Joshua Labaer , Zehra Ilhan
- Applicant: Arizona Board of Regents
- Applicant Address: US AZ Scottsdale
- Assignee: Arizona Board of Regents
- Current Assignee: Arizona Board of Regents
- Current Assignee Address: US AZ Scottsdale
- Main IPC: A61K35/741
- IPC: A61K35/741 ; G01N33/68 ; C12Q1/689 ; C12Q1/6883 ; A61K31/437

Abstract:
The present disclosure provides for characterization of normal flora and identifying biomarkers in the gut of healthy, neurotypical subjects. Aspect of the disclosure provide for the characterization of the gut microbiome in ADS subjects, characterized by reduced richness and significant loss of the ‘Prevotella-like enterotype’ compared to neurotypical subjects. The relative abundance of genera Prevotella, Coprococcus, Prevotellaceae and Veillonellaceae are significantly lower in autistic children than in neurotypical children. Further, Prevotella, is one of the three main classifiers for the human enterotypes, along with Bacteriodes and Ruminococcus. These three core genera are among main contributors in the principle component analysis. ‘Prevotella-like enterotype’ was absent in the autistic group, while neurotypical samples showed an even distribution among the three enterotypes. The present disclosure provides for an understanding the association between gut microbiota, health, and disease states, and provides for potential diagnostic and therapeutic targets.
Public/Granted literature
- US20190144923A1 Microbiome Markers and Therapies for Autism Spectrum Disorders Public/Granted day:2019-05-16
Information query
IPC分类: